<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Parkside Surgery</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+P84644">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Parkside Surgery is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0906040P0&amp;denomIds=9.6.4&amp;selectedTab=summary">Paricalcitol</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>5</td>&#13;
      <td>Vitamin D</td>&#13;
      <td>896</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>39.14</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0906040P0BBACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Zemplar 1microgram capsules : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0504010L0&amp;denomIds=5.4.1&amp;selectedTab=summary">Mefloquine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Antimalarials</td>&#13;
      <td>50</td>&#13;
      <td>0.02</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>15.70</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0504010L0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Mefloquine 250mg tablets : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0208020W0&amp;denomIds=2.8.2&amp;selectedTab=summary">INR blood testing reagents</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>6</td>&#13;
      <td>Oral anticoagulants</td>&#13;
      <td>134</td>&#13;
      <td>0.04</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>15.29</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0208020W0BBABA0&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">CoaguChek XS PT testing strips : 6</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0601023AP&amp;denomIds=6.1.2&amp;selectedTab=summary">Canagliflozin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>80</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>1421</td>&#13;
      <td>0.06</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>13.53</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0601023APAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Canagliflozin 50mg / Metformin 1g tablets : 80</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0504010U0&amp;denomIds=5.4.1&amp;selectedTab=summary">Proguanil hydrochloride with atovaquone</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Antimalarials</td>&#13;
      <td>50</td>&#13;
      <td>0.02</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>11.51</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0504010U0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Proguanil 100mg / Atovaquone 250mg tablets : 1</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Parkside Surgery is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0&amp;denomIds=15.2.1&amp;selectedTab=summary">Lidocaine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>23</td>&#13;
      <td>Local anaesthetics</td>&#13;
      <td>84</td>&#13;
      <td>0.27</td>&#13;
      <td>0.91</td>&#13;
      <td>0.14</td>&#13;
      <td>-4.56</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0AAELEL&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 5% medicated plasters : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0AABYBY&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 2.5% / Prilocaine 2.5% cream : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0BVAAEQ&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Bonjela Junior gel : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0BEAABY&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Emla 5% cream : 6</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=1502010J0BWAAEL&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Ralvo 700mg medicated plasters : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0&amp;denomIds=7.3.2&amp;selectedTab=summary">Desogestrel</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>32</td>&#13;
      <td>Oral progestogen-only contraceptives</td>&#13;
      <td>46</td>&#13;
      <td>0.70</td>&#13;
      <td>0.94</td>&#13;
      <td>0.05</td>&#13;
      <td>-4.47</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0BFAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Desorex 75microgram tablets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0AAAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Desogestrel 75microgram tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0BDAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Cerelle 75microgram tablets : 17</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0BHAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Zelleta 75microgram tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0703021Q0BBAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Cerazette 75microgram tablets : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0802010G0&amp;denomIds=8.2.1&amp;selectedTab=summary">Azathioprine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Antiproliferative immunosuppressants</td>&#13;
      <td>9</td>&#13;
      <td>0.00</td>&#13;
      <td>0.80</td>&#13;
      <td>0.19</td>&#13;
      <td>-4.33</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>4</td>&#13;
      <td>Aminosalicylates</td>&#13;
      <td>34</td>&#13;
      <td>0.12</td>&#13;
      <td>0.64</td>&#13;
      <td>0.15</td>&#13;
      <td>-3.55</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0105010B0AAAPAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg gast res MR gran sachets sugar free : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0604011G0&amp;denomIds=6.4.1&amp;selectedTab=summary">Estradiol</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2</td>&#13;
      <td>Oestrogens and Hormone Replacement Therapy</td>&#13;
      <td>20</td>&#13;
      <td>0.10</td>&#13;
      <td>0.46</td>&#13;
      <td>0.14</td>&#13;
      <td>-2.56</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84644&amp;numIds=0604011G0BUABBN&amp;denomIds=6.4.1&amp;selectedTab=summary" target="_blank">Estradot 100micrograms/24hours patches : 2</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>